Journal article
Adalimumab Efficacy in Hidradenitis Suppurativa Patients is Sustained at Least Three Years with Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)
Christos C Zouboulis, Martin M Okun, Robert Gniadecki, Peter A Foley, Charles Lynde, Jamie Weisman, Piyalal Karunaratne, David A Williams
SKIN The Journal of Cutaneous Medicine | Dermsquared | Published : 2017
Abstract
Abstract Not AvailableDisclosures: Study supported by AbbVie.